Induction of fetal hemoglobin in sickle cell disease

被引：38

作者：

Bunn, HF ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA

来源：

BLOOD | 1999年 / 93卷 / 06期

关键词：

D O I：

10.1182/blood.V93.6.1787.406a34_1787_1789

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1787 / 1789

页数：3

共 24 条

[1]

Atweh GF, 1999, BLOOD, V93, P1790

[2] EFFECT OF HYDROXYUREA ON THE RHEOLOGICAL PROPERTIES OF SICKLE ERYTHROCYTES INVIVO [J].

BALLAS, SK ;

DOVER, GJ ;

CHARACHE, S .

AMERICAN JOURNAL OF HEMATOLOGY, 1989, 32 (02) :104-111

[3] A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy [J].

Bridges, KR ;

Barabino, GD ;

Brugnara, C ;

Cho, MR ;

Christoph, GW ;

Dover, G ;

Ewenstein, BM ;

Golan, DE ;

Guttmann, CRG ;

Hofrichter, J ;

Mulkern, RV ;

Zhang, B ;

Eaton, WA .

BLOOD, 1996, 88 (12) :4701-4710

[4] Mechanisms of disease - Pathogenesis and treatment of sickle cell disease [J].

Bunn, HF .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :762-769

[5] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].

CHARACHE, S ;

TERRIN, ML ;

MOORE, RD ;

DOVER, GJ ;

BARTON, FB ;

ECKERT, SV ;

MCMAHON, RP ;

BONDS, DR ;

ORRINGER, E ;

JONES, S ;

STRAYHORN, D ;

ROSSE, W ;

PHILLIPS, G ;

PEACE, D ;

JOHNSONTELFAIR, A ;

MILNER, P ;

KUTLAR, A ;

TRACY, A ;

BALLAS, SK ;

ALLEN, GE ;

MOSHANG, J ;

SCOTT, B ;

STEINBERG, M ;

ANDERSON, A ;

SABAHI, V ;

PEGELOW, C ;

TEMPLE, D ;

CASE, E ;

HARRELL, R ;

CHILDERIE, S ;

EMBURY, S ;

SCHMIDT, B ;

DAVIES, D ;

KOSHY, M ;

TALISCHYZAHED, N ;

DORN, L ;

PENDARVIS, G ;

MCGEE, M ;

TELFER, M ;

DAVIS, A ;

CASTRO, O ;

FINKE, H ;

PERLIN, E ;

SITEMAN, J ;

GASCON, P ;

DIPAOLO, P ;

GARGIULO, S ;

ECKMAN, J ;

BAILEY, JH ;

PLATT, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322

[6]

CHARACHE S, 1987, BLOOD, V69, P109

[7] Hydroxyurea and sickle cell anemia - Clinical utility of a myelosuppressive ''switching'' agent [J].

Charache, S ;

Barton, FB ;

Moore, RD ;

Terrin, ML ;

Steinberg, MH ;

Dover, GJ ;

Ballas, SK ;

McMahon, RP ;

Castro, O ;

Orringer, EP ;

Jones, S ;

Strayhorn, D ;

Rosse, W ;

Phillips, G ;

Peace, D ;

JohnsonTelfair, A ;

Milner, P ;

Kutlar, A ;

Tracy, A ;

Allen, GE ;

Moshang, J ;

Steinberg, M ;

Anderson, A ;

Sabahi, V ;

Pegelow, C ;

Temple, D ;

Case, E ;

Harrell, R ;

Embury, S ;

Schmidt, B ;

Koshy, M ;

TalischyZahed, N ;

Dorn, L ;

Pendarvis, G ;

McGee, M ;

Telfer, M ;

Davis, A ;

Finke, H ;

Perlin, E ;

Siteman, J ;

Gascon, P ;

diPaolo, P ;

Gargiulo, S ;

Eckman, J ;

Bailey, JH ;

Platt, A ;

Waller, L ;

Ramirez, G ;

Knors, V ;

Hernandez, S .

MEDICINE, 1996, 75 (06) :300-326

[8]

CONSTANTOULAKIS P, 1989, BLOOD, V74, P1963

[9] THE BIOPHYSICS OF SICKLE-CELL HYDROXYUREA THERAPY [J].

EATON, WA ;

HOFRICHTER, J .

SCIENCE, 1995, 268 (5214) :1142-1143

[10] Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial [J].

Ferster, A ;

Vermylen, C ;

Cornu, G ;

Buyse, M ;

Corazza, F ;

Devalck, C ;

Fondu, P ;

Toppet, M ;

Sariban, E .

BLOOD, 1996, 88 (06) :1960-1964

← 1 2 3 →